Cargando…
Analysis of Serial Neuroblastoma PDX Passages in Mice Allows the Identification of New Mediators of Neuroblastoma Aggressiveness
Neuroblastoma is a neural crest cell-derived pediatric tumor characterized by high inter- and intra-tumor heterogeneity, and by a poor outcome in advanced stages. Patient-derived xenografts (PDXs) have been shown to be useful models for preserving and expanding original patient biopsies in vivo, and...
Autores principales: | Gómez-Muñoz, María A., Aguilar-Morante, Diana, Colmenero-Repiso, Ana, Amador-Álvarez, Aida, Ojeda-Puertas, Mónica, Cordero Varela, Juan Antonio, Rodríguez-Prieto, Ismael, Pardal, Ricardo, Vega, Francisco M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866967/ https://www.ncbi.nlm.nih.gov/pubmed/36675105 http://dx.doi.org/10.3390/ijms24021590 |
Ejemplares similares
-
CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours
por: Vega, Francisco M., et al.
Publicado: (2019) -
Corrigendum to ‘CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours’ [EBioMedicine 49 (2019) 82–95]
por: Vega, Francisco M., et al.
Publicado: (2020) -
Neural crest derived progenitor cells contribute to tumor stroma and aggressiveness in stage 4/M neuroblastoma
por: Linares-Clemente, Pedro, et al.
Publicado: (2017) -
Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma”
por: Vega, Francisco M., et al.
Publicado: (2020) -
Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation
por: Colmenero-Repiso, Ana, et al.
Publicado: (2020)